Last updated on January 2017

Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML


Brief description of study

Assessment of safety and tolerability of drug combination and determine time on treatment, Overall survival (OS) and response rate with patient disease burden, and type of disease

Clinical Study Identifier: NCT02875093

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ta-Chih Liu, MD

Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
  Connect »